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SUMMARY 
Prostaglandin E, and a CAMP phosphodiesterase inhibitor 4-(3-butoxy-4-methoxybenzyl)-2- 
imidazolidinone, R020-1724, were used to induce differentiation in mouse neuroblastoma cells in 
culture. The incorporation of amino acids and phosphate into nuclear proteins of control and 
drug-treated cells (1 h and 3 days after treatment) was examined using double radioisotopic 
techniques. A marked decrease in histone synthesis and HI-histone phosphorylation were 
observed in ‘differentiated’ neuroblastoma cells after 3 days of prostaglandin E, and R020-1724 
treatment, but only small differences were noted in the synthesis and phosphorylation of non- 
histone chromatin associated proteins after 3 days of drug treatment. Minimal changes were 
observed in the labeling of histone and non-histone nuclear proteins if the cells were treated for 
1 h with prostaglandin E, and R020-1724. 
An elevation of the intracellular level 
of adenosine 3’S’-cyclic monophosphate 
(CAMP) by prostaglandin E, (PGE,), in- 
hibitors of phosphodiesterase (papaverine 
and R020-1724) or by analogs of CAMP 
(N6J12’-dibutyryl cyclic AMP and gbenzyl- 
thio CAMP) induces many differentiated 
functions which are characteristic of mature 
neurons. These include formation of long 
neurites [19], increase in size of soma and 
nucleus associated with a rise in total RNA 
and proteins [19, 201, increase in total 
mRNA content [2], increases in tyrosine 
hydroxylase [28, 351, choline acetyltrans- 
ferase [ 16, 201, and acetylcholinesterase 
[6, 201 activities, increase in stimulation of 
adenylate cyclase activity in vitro by cate- 
cholamines [2 l] and acetylcholine [22], 
potentiation of PGE,-stimulated adenylate 
cyclase activity in vitro by guanosine tri- 
phosphate [22], increase in CAMP phospho- 
diesterase activity [23] and decrease in tu- 
morigenicity [20]. 
The synthesis of histones [9, 111 and the 
phosphorylation of Hl-histone [l, lo] ap- 
pear to be associated with proliferating cells 
and occur predominantly in the S phase of 
the cell cycle. Since CAMP-induced ‘dif- 
ferentiated’ neuroblastoma cells stop cell 
division [20], it is possible that these nu- 
clear events are turned off in ‘differentiated 
neuroblastoma cells. Furthermore, qualita- 
tive and quantitative changes in non-histone 
chromosomal proteins (NHCP) have been 
observed during development in slime mold 
[13], the chick oviduct [32], and the sea 
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urchin [30]. Stage specific NHCP phos- related with the maintenance of a differentiated state. 
phorylation has been found in the matura- On the day of experiment, the growth medium was 
tion of sea urchin [ 181 and avian red blood 
changed before the addition of radioisotopes. “C- or 
3H-labeled amino acid mixtures (l-2 &i/ml) were 
cells [7]. These findings suggest that added to control and treated cultures, respectively. In 
changes in the synthesis and/or phos- 
another set of experiments, 32P and 33P (8-12 &i/ml) 
were added to control and treated cultures, respec- 
phorylation of NHCP may be involved in tively. Cells (5x IO’) were removed from the flask sur- 
the regulation of differentiated functions. 
face by Viokase solution (0.25%), washed twice with 
growth medium and twice with a phosphate-buffered 
We have therefore compared the synthesis saline (pH 6.5). Cells were 90% viable as measured 
and phosphorylation of histone and non- 
by trypan blue dye exclusion at the time of harvest. 
histone chromosomal proteins in control zsolarion Of chromatin 
and CAMP-induced ‘differentiated’ mouse 
neuroblastoma cells in culture. We now re- 
port that the synthesis of histone and the 
phosphorylation of H I-histone are mark- 
edly decreased in CAMP-induced differen- 
tiated neuroblastoma cells, but there is no 
prominent change in the synthesis or phos- 
phorylation of non-histone chromosomal 
proteins. 
MATERIALS AND METHODS 
L-[G-3H]amino acid mixtures, L-[U-Y]amino acid 
mixtures, 32Pi and 33Pi were obtained from New Eng- 
land Nuclear Corp. F-12 medium and Viokase (2.5%) 
were purchased from Grand Island Biological Co. 
PGE, was a gift from Dr J. E. Pike of Upjohn Com- 
pany, and R020-1724 was donated by Dr H. Sheppard 
of Hoffmann-LaRoche, Inc. Calf thymus histones 
were obtained from Sigma Chemical Co. 
Cell culture and radiolabeling 
Procedures for culturing and maintaining the mouse 
neuroblastoma cells were previously described [ 191. 
Cells of clone NBA*(,, were used in this study. These 
cells contained a marker enzvme for neural tissue, 
tyrosine hydroxylase [25]. Differentiation was induced 
by PGE,, which stimulates adenylate cyclase activity 
by about 2-fold [21], and by 4-(3-butoxy-4-methoxy- 
benzyl)-2-imidazolidinone (R020-1724) which inhibits 
CAMP phosphodiesterase activity by over 90% with- 
out affecting cGMP phosphodiesterase activity [26] in 
neuroblastoma cells. 
Cells (0.5~ 1Oa) were plated in Falcon flasks (75 
cm*). PGE, (10 pg/ml) and R020-1724 (200 @g/ml) 
were added separately 24 h after plating. The drug and 
medium were changed daily. Control cultures were 
treated identically except that an equivalent volume of 
solvent without drug was added. Chromatin associated 
proteins were analysed (1) 1 h after drug treatment in 
order to identify changes which might be involved in 
the initiation of morphological and biochemical matu- 
ration; (2) 72 h after drug treatment in order to ob- 
serve whether there were changes which could be cor- 
All procedures were carried out at 0°C. Chromatin was 
isolated by a modification of the procedure described 
by Weisenthal & Ruddon [37]. Control and treated cell 
pellets were combined to insure eauivalent handline 
during the extraction procedure and suspended in a 
buffer (nH 6.5) containing 500 mM 2-methvl-3. 4- 
pentanediol, I.6 mM CaCI;, and 0.1 mM piperazine- 
N-N’-his (2-ethanesulfonic acid) monosodium mono- 
hydrate (PIPES). After standing for I5 min, the cells 
were sheared with a tight pestle in a Dounce homo- 
genizer until more than 90% of the nuclei were ren- 
dered free of cytoplasmic tags as observed by phase 
contrast microscopy. 
The crude nuclear suspension was immediatelv pel- 
leted (I 000 g, IO min) and washed twice with 2.0-i-m of 
a solution containing 250 mM sucrose, 10 mM Tris- 
HCI, 5.0 mM NaHSG,, 5.0 mM MgC&, and 5.0 mM /3- 
mercaptoethanol (pH 7.4). The washed nuclei were 
lysed by the addition of 2.0 ml of a solution containing 
24 mM EDTA, 75 mM NaCI, and 5 mM NaHSO, (pH 
7.0). After centrifugation of this suspension at I500 g 
for IO min, the pellet was washed twice (1.0 ml) with 
each of the followine buffered IPH 8.0) solutions to iso- 
late chromatin: (I) 50 mM Tris-HCl;‘(2) IO mM Tris- 
HCI: and (3) I.0 mM Tris-HCI. After each wash the 
sample was centrifuged for 10 min at I500 g. Previous 
experiments (Lazo & Ruddon, unpublished) demon- 
strated that >95 % of the total cellular DNA was found 
in the chromatin pellet. In order to assess the ability of 
the method to remove contaminating cytoplasmic pro- 
teins from chromatin, radiolabeled post-nuclear super- 
natant proteins were added to unlabeled purified 
neuroblastoma nuclei in a separate experiment. Less 
than 0.3 % of labeled cytoplasmic proteins were found 
in the chromatin pellet. The protein to DNA ratio in 
the chromatin prepared by this method was 2.84f0.4 
(S.E.M.). 
Extraction of nuclear proteins 
Proteins were extracted from chromatin by a modifica- 
tion of the procedure of Weisenthal & Ruddon [37]. 
Two 30 min (2.0 ml) extractions with a buffer (pH 7.0) 
containing 300 mM NaCI, IO mM Tris-HCI, 5.0 mM 
MgCI,, 5.0 mM NaHS03, and 5.0 mM p-mercapto- 
ethanol were used to remove the 0.3 M NaCl soluble 
non-histone chromatin-associated proteins. Following 
the salt extraction, histones were removed with three 
1 h (1.5 ml) extractions with 0.25 N HCI. Lipids were 
extracted by 3 washes (2.0 ml) in 80 % ethanol : IO mM 
Tris-HCI, 50 % chloroform : 50 % methanol, and 75 % 
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Table 1. Distribution of total chromatin- Protein banding patterns obtained by SDS 




Fraction protein S.E.M. 







SU-NHCP, SDS, urea soluble non-histone chromatin- 
associated proteins. Protein determinations are based 
on the method of Lowry et al. [14]. 
ethanol : 25 % ether, respectively. The pellet resulting 
from the final 1500 g, 10 min centrifugation was 
suspended in a buffer solution (pH 6.9) containing 1% 
sodium dodecvl sulfate (SDS), 4.0 M urea, IO mM 
NaH,PO, and-5.0 mM P-mercaptoethanol. This sus- 
pension was disrupted by three 15 set treatments 
with a Tekmar Tissuemizer, boiled for 3 min, and 
stirred for I h at 25°C to remove most of the proteins 
associated with DNA. The proteins which remained in 
the supernatant after a 100000 g, 16 h centrifugation 
were termed SDS-urea soluble non-histone chromatin- 
associated proteins (SU-NHCP), and the proteins 
found in the pellet were termed residual non-histone 
chromatin-associated proteins. 
To insure complete removal of phospholipids and 
nucleic acids in the exoeriment desiened to studv the 
phosphorylation of n&ear proteins; h after addition 
of PGE, and R020-1724, the dehistonized lipid-free 
chromatin was extracted by the phenol procedure of 
Teng et al. [34]. DNA and RNA were removed in the 
aqueous phase while a majority of the NHCP entered 
the phenol phase. 
Gel electrophoresis 
Electrophoresis was conducted on 0.1% SDS, 10% 
polyacr$amide gels (8 mm diameterx 10 cm length) for 
18-21 h as described bv Weisenthal & Ruddon [371. 
The slices were placed in counting vials with-6% 
Protosol in toluene scintillator (8 g, 2,5-diphenyl- 
oxazole/l), incubated for 3 days at 37°C and counted 
on a Packard-Tri Carb liquid scintillation spectro- 
meter. The data were corrected to dpm and plotted as 
percent of total dpm for each isotope utilizing com- 
puter programs designed by P. M. Schwartz & J. 
Drach (personal communication). The average count- 
ing efficiency for each isotope was as follows: DH 
(26%), 14C (52%), 33P (67%), 32P (89%). Molecular 
weight determinations were made using the method of 
Weber & Osborne [36]. 
Protein determination 
Protein determinations were made with a modification 
of the method of Lowry et al. [14], using bovine serum 
albumin as a standard. 
Each fraction exhibited a typical, reproducible pattern 
of polypeptides on SDS-polyacrylamide gels. The 
0.25 N HCI fraction contained a polypeptide band with 
an apparent molecular weight of 22000 D which co- _ 
electrophoresed with calf thymus HI-histone. Low 
molecular weight histones (H3. H2b. H2a. and H4) 
migrated together as a single dense band with an ap- 
parent molecular range of I 1000 to 14000 D. Although 
negligible amounts of histones were found in the other 
nuclear protein fractions, the 0.25 N HCI extract 
(histone fraction) contained small amounts of high 
molecular weight proteins which represented conta;i- 
nation of this fraction by non-histone proteins. The 
SU-NHCP and residual NHCP obtained-by extraction 
of dehistonized chromatin with 1% SDS--I M urea 
were characterized on SDS gels as a heterogeneous 
group of polypeptides. The molecular weight of most 
of these polypeptides ranged from 30000 to 150000 D. 
Similar observations were made with the non-histone 
protein extracts which were obtained from de- 
histonized chromatin by treatment with phenol; that is, 
NHCP present in both the phenol and aqueous phases 
were free of histones and contained primarily high 
molecular weight polypeptides. Recently, Suria & 
Liew [33] have reported that the phenol and SDS 
methods extract similar classes of NHCP. 
RESULTS 
Distribution of chromatin-associated 
proteins 
Table 1 illustrates the protein content of the 
chromatin extracts from the pooled control 
and treated cell samples. The 0.3 M NaCl 
soluble NHCP fraction contained the lowest 
amount of chromatin-associated protein, 
and the histone fraction contained the 
highest amount of protein. About 70% of 
the proteins which remained associated 
with dehistonized chromatin were removed 
with 1% SDS4 M urea, whereas 55% of 
these proteins were extracted into phenol. 
Incorporation of amino acids into histone 
and non-histone chromosomal proteins 
(NHCP) 
A marked decrease in the amino acid in- 
corporation into histones (fig. IA) was ob- 
served after 3 days of treatment of neuro- 
blastoma cells with PGE, and R020-1724. 
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Fig. I. Abscissa: mm; ordinate (A) dpm; (B) % 
total dpm. 
Distribution of radiolabeled amino acids in SDS 
polyacrylamide gels of histone fractions from control 
and differentiated cells. Seventy-two hours after the 
addition of PGE, and R020-1724 or vehicle, control 
and treated cells (5x IO’) were labeled with [“Cl or 
[3H]amino acids for 2 h. Gels were cut into I mm 
slices and the radioactivity in control (0 - - - 0) and 
treated (O--O) was determined. (A) 0.25 N HCI frac- 
tion; (B) 0.25 N HCI fraction, total dpm, ‘T-25 133, 
3H-8975. Gels were run 17.5 h at 6 mA/gel. Direction 
of migration is from left to right. H histone slices 
2%35. 
In the treated cells there was a greater de- 
crease in amino acid incorporation into the 
lower molecular weight histones than into 
Hl histone. This accounted for the apparent 
increase in the Hl histone contribution to 
the treated cell histone fraction when the 
data are plotted as percent total dpm (fig. 
1 II). There was no significant difference in 
the amino acid incorporation into histones 
between control and neuroblastoma cells 
which were treated with PGE, and R020- 
1724 for only 1 h (data not shown). 
The incorporation of amino acids into 
NHCP did not significantly change in 
neuroblastoma cells treated with PGE, and 
R020-1724 for 1 h. There was, however, a 
small decrease in the incorporation of amino 
acids into a 40000 mol. wt peak in both 
the SU-NHCP and residual NHCP frac- 
tions of cells treated for 3 days (fig. 2). 
Incorporation of phosphate into histone 
and non-histone chromosomal proteins 
(NHCP) 
The phosphorylation of HI-histone was 
markedly decreased in neuroblastoma cells 
3 days after treatment with PGE, and R020- 
1724 (fig. 3A); however, no significant 
change was observed if the neuroblastoma 
cells were treated with drugs for only 1 h 
(data not shown). There was no significant 
difference in the incorporation of radio- 
active phosphate into the 0.3 M NaCl sol- 
uble fractions of neuroblastoma cells when 
they were treated with PGE, and R020- 
1724 for 1 h or 3 days. However, a small in- 
crease in incorporation of phosphate into a 
/ 
I 
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Fig. 2. Abscissa: mm; ordinate: % total dpm. 
Distribution of radiolabeled amino acids in SDS 
polyacrylamide gels of various fractions from con- 
trol and 72 h treated cells. Procedure and symbols 
same as fig. 1. (A) SU-NHCP, total dpm T-24577, 
3H-12413; (B) residual-NHCP, total dpm, T-50658, 
3H-25588. Gels were run for 20 h at 6 mA/gel. Ar- 
rows mark 40000 D peaks. 
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Fig. .?. Abscissa: mm; ordinate: % total dpm. 
Distribution of radiolabeled phosphate in SDS 
polvacrvlamide gels of various fractions from control 
An6 diff<rentiate5d cells. Seventy-two hours after the 
addition of PGE, and R020-1724 or vehicle. control 
and treated cells’(5x 10’) were labeled with 32P or 33P 
for 2 h. Gels were cut into I mm slices and the 
radioactivity in control (0 - - -0) and treated (Cl--O) 
was determined. (A) 0.25 N HCI fraction. total dam. 
3zP-110414, 33P-4$$31; (B) SU-NHCP, ‘total dim, 
32P-298079, 33P-108670. Gels were run for 21 h at 
6 mA/gel. Arrow marks 40000 D peak. H, histone 
slices 38-44. 
40 000 D polypeptide of SU-NHCP fractions 
was observed in ‘differentiated’ cells (fig. 
3B). 
DISCUSSION 
The results of this study demonstrate that 
a marked decrease in histone synthesis 
and H I-histone phosphorylation occurs in 
CAMP-induced ‘differentiated’ neuro- 
blastoma cells. Studies with a number of 
inhibitors of cell division show that the 
synthesis of histones is correlated with the 
proliferative state of a cell [ 1, 9-l 11. Thus, 
the decrease in histone synthesis most 
likely reflects the Cl phase arrest of the 
differentiated cells. It is of interest that 
Hl-histone phosphorylation is markedly 
decreased in the differentiated cells at a 
time when Hl synthesis is relatively less 
decreased than the other histones. The 
reason for this is not clear but it may 
indicate that H I-histone phosphorylation 
is more tightly coupled to cell prolifera- 
tion than is its synthesis. 
A change in Hl-histone phosphoryla- 
tion is not observed in dividing neuro- 
blastoma cells 1 h after treatment with 
PGE, and R020-1724 even though these 
cells have an increased CAMP content 
[24]. H I-histone phosphorylation is con- 
trolled by at least two kinase activities; 
one that is CAMP-dependent and unas- 
sociated with cell division, and a second 
that is most active during DNA synthesis 
and does not appear to be regulated by 
CAMP [IS]. A reduction in Hl-histone 
phosphorylation is observed only in cells 
treated for 72 h. Since the CAMP levels 
are elevated in both proliferating (1 h 
drug-treated) [24] and non-proliferating 
(72 h drug-treated) neuroblastoma cells 
[29], it appears that phosphorylation of 
neuroblastoma Hl-histone is mediated by 
a proliferation-dependent protein kinase. 
The possibility that neuroblastoma cells 
also contain a CAMP-dependent Hl- 
histone kinase activity is not ruled out by 
these data, since only a small percentage 
of H I-histone phosphorylation is mediated 
by a CAMP-dependent kinase [12]. Neither 
do these data preclude the possible im- 
portance of CAMP-mediated histone phos- 
phorylation in the differentiation process 
[311. 
In contrast to histone synthesis and Hl- 
histone phosphorylation, no significant 
change occurs in either the synthesis or 
phosphorylation of non-histone chromo- 
somd proteins in CAMP-induced dif- 
ferentiated neuroblastoma cells. Other in- 
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vestigators [3, 5, 171 have been unable to 
demonstrate any significant changes in 
NHCP during development of rat brains, 
The significance of the small decrease in 
the synthesis and the small increase in 
the phosphorylation of 40000 D peptides 
in differentiated neuroblastoma cells, in 
which DNA synthesis is markedly reduced 
[27], is not presently known. It has been 
suggested that a non-histone protein of the 
4Oooo-45 000 D range may be involved in 
DNA replication in eukaryotic cells [4]. 
Thus, the observed changes in the syn- 
thesis and phosphorylation of chromatin- 
associated proteins in differentiated neuro- 
blastoma cells seem to reflect primarily 
the shift from a proliferating to a non- 
proliferating cell population. Whether any 
of these effects are involved in switching 
on specific differentiated functions is not 
evident. A correlation of these effects with 
the transcription of a specific gene prod- 
uct, for example, with the appearance of 
significant amounts of mRNA coding for 
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